Browsing by Author Adams, Seray

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2015Cytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2Akerfeldt, Mia; Chircop (nee Fabbro), Megan; Gurgis, Fadi; Munoz, Lenka; Wong, Chin; Adams, Seray; Guillemin, Gilles J.; Heng, Benjamin; Johns, Terrance G; Chemistry; Childrens Medical Research Institute (CMRI); School of Medical Sciences: Pharmacology; School of Medical Sciences: Pathology; Children's Hospital Westmead: Childrens Medical Research InsCytotoxic activity of the MK2 inhibitor CMPD1 in glioblastoma cells is independent of MK2, Cell Death Discovery, vol.1, N/A, 2015,pp 1-11
2014Involvement of the Kynurenine Pathway in Human Glioma PathophysiologyZinger, Anna; Adams, Seray; Braidy, Nady; Brew, Bruce J.; Bustamante, Sonia; Guillemin, Giles; Lim, Chai K; McDonald, Kerrie; Sundaram, Gayathri; Teo, Charlie; School of Medical Sciences: PathologyInvolvement of the Kynurenine Pathway in Human Glioma Pathophysiology, PloS One, vol.9, 11, 2014,pp 1-28
2012p38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cellsBryce, Nicole; Grewal, (Ranjit) Thomas; Konayagi, Mari; Munoz (nee Gyurosiova), Lenka; Yeung, Otto Yiu To; Adams, Seray; Braidy, Nady; Guillemin, Gilles; McDonald, K; Teo, Charlie; Chemistry; Pharmacy; Pharmacy; Pharmacy; Pharmacyp38 MAPK inhibitors attenuate pro-inflammatory cytokine production and the invasiveness of human U251 glioblastoma cells, Journal of Neuro-Oncology, vol.109, 1, 2012,pp 35-44